Malignant Mesothelioma Clinical Trials

77 clinical trials for Malignant Mesothelioma across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease — RECRUITING · PHASE1
• A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma — RECRUITING · PHASE2
• Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery — RECRUITING · PHASE2
• Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors — RECRUITING · PHASE1
• Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors — RECRUITING · PHASE1
• Phase II study of sorafenib in malignant mesothelioma previously treated with platinum-based chemotherapy — COMPLETED · PHASE4
• Tazemetostat Expanded Access Program for Adults With Solid Tumors — TERMINATED
• Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma — SUSPENDED · PHASE2
• Rehabilitation by Effort for Patients With Advanced Bronchial Cancer — TERMINATED · NA
• Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery — COMPLETED · PHASE1
• Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma — WITHDRAWN · PHASE2
• Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma — NOT_YET_RECRUITING · PHASE1
• Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma — COMPLETED · PHASE2
• 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors — TERMINATED · PHASE2
• Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers — COMPLETED · PHASE3
• A Study to Investigate 14C-bemcentinib in Healthy Male Subjects — COMPLETED · PHASE1
• Dendritic Cell Vaccination for Patients with Solid Tumors — COMPLETED · PHASE1
• Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors — OTHER · PHASE1
• A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors — COMPLETED · PHASE1
• Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma — COMPLETED · PHASE1
• Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients — COMPLETED
• Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesothelioma — TERMINATED · PHASE1
• A Study of LY3023414 in Participants With Advanced Cancer — COMPLETED · PHASE1
• Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy — COMPLETED · PHASE2
• Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours — OTHER · PHASE1
• Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma — TERMINATED · PHASE2
• Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer — COMPLETED · PHASE2
• S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery — COMPLETED · PHASE2
• Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer — COMPLETED · NA
• Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma — COMPLETED · PHASE2
• Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinical Trial CALGB-30107 — TERMINATED
• Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma — COMPLETED · PHASE2
• IP3R Modulation by Cancer Genes in Mesothelioma — OTHER
• Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma — COMPLETED · PHASE2
• Collecting Tumor Samples From Patients With Gynecological Tumors — COMPLETED
• Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma — COMPLETED · PHASE2
• Capecitabine in Treating Patients With Malignant Mesothelioma — COMPLETED · PHASE2
• PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma — COMPLETED · PHASE2
• Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma — COMPLETED · PHASE1
• Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso — OTHER · PHASE1
• Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease — WITHDRAWN
• Immunotoxin Therapy in Treating Patients With Advanced Cancer — COMPLETED · PHASE1
• Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura — COMPLETED · PHASE1
• Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma — TERMINATED · PHASE2
• Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma — COMPLETED · PHASE2
• Bortezomib in Treating Patients With Malignant Pleural Mesothelioma — COMPLETED · PHASE2
• Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite — COMPLETED
• Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer — OTHER · PHASE2

Refine this search